PRLD vs TRMB · rev $6.5M vs P/E 26, rev $3.68B
Prelude Therapeutics Inc (PRLD) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported TRMB revenue for 2025-01-03 was $3.68B. Net income was $1.50B. Revenue was down 3.0% from 2023-12-29 to 2025-01-03. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
PRLD currently screens at market cap $346.5M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the PRLD and TRMB stock pages for the full models.
Not investment advice.